Therapy of systemic lupus erythematosus: new agents and new evidence.
about
Antimalarial therapy selection for quinolone resistance among Escherichia coli in the absence of quinolone exposure, in tropical South AmericaUpdate on therapy--thalidomide in the treatment of lupus.Immunosuppressants in advanced clinical development for organ transplantation and selected autoimmune diseases.Mycophenolate mofetil in solid-organ transplantation.Mycophenolate in dermatology.Basic immunosuppressive drugs outside solid organ transplantation.
P2860
Therapy of systemic lupus erythematosus: new agents and new evidence.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Therapy of systemic lupus erythematosus: new agents and new evidence.
@ast
Therapy of systemic lupus erythematosus: new agents and new evidence.
@en
Therapy of systemic lupus erythematosus: new agents and new evidence.
@nl
type
label
Therapy of systemic lupus erythematosus: new agents and new evidence.
@ast
Therapy of systemic lupus erythematosus: new agents and new evidence.
@en
Therapy of systemic lupus erythematosus: new agents and new evidence.
@nl
prefLabel
Therapy of systemic lupus erythematosus: new agents and new evidence.
@ast
Therapy of systemic lupus erythematosus: new agents and new evidence.
@en
Therapy of systemic lupus erythematosus: new agents and new evidence.
@nl
P2860
P50
P1476
Therapy of systemic lupus erythematosus: new agents and new evidence.
@en
P2860
P304
P356
10.1517/13543784.9.7.1581
P407
P577
2000-07-01T00:00:00Z